Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FZK10
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,137
Award facts
- Contract value 100% obligated
- $5,136.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,136.66 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/mL autoinjectors. This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a discrete procurement action under the company's existing Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete as a woman-owned small business in the broader federal pharmaceutical supply marketplace.
DMS Pharmaceutical Group Inc., based in Park Ridge, Illinois, is an established pharmaceutical wholesaler that has served as a critical supplier within the federal healthcare supply chain since its SAM.gov registration in 2001. The company holds a substantial single-award IDC with the DLA valued at $499,999,999 through November 2026 under the SPE2DB program, which authorizes delivery orders for a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. This Xolair delivery order exemplifies the routine procurement activities supporting Department of Defense healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FZK10?
SPE2DB25FZK10 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FZK10 worth?
The government has obligated $5,137 on SPE2DB25FZK10.
Is contract SPE2DB25FZK10 an order under another contract?
Yes. SPE2DB25FZK10 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZK10 competed?
The extent of competition for SPE2DB25FZK10 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award